Pure Global AI
Registration holder profile

SUPER DIAGNOSTICA PRODS HOSP LTDA EPP

Brazil4 ANVISA registrations4 unique technical categoriesFeb 17, 2025 – Aug 11, 2025
Verified
4
Total products
4
Technical names
Feb 2025
Earliest registration
Aug 2025
Latest registration
Regulatory footprint
Search SUPER DIAGNOSTICA PRODS HOSP LTDA EPP across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING
Neonatal 17-OH-Progesterone FEIA
Class III · Aug 11, 2025
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING
Neonatal G6PD
Class III · Jul 21, 2025
VITAMIN C (ASCORBIC ACID)
Família Vitamin C
Class II · Apr 28, 2025
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
Família Vitamin A&E
Class II · Feb 17, 2025
Most popular products
Products with most registrations
17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING
1 registrations
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING
1 registrations
VITAMIN C (ASCORBIC ACID)
1 registrations
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
1 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
LABSYSTEMS DIAGNOSTICS OY
4 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class II2Distinct Products · 2 total registrations
Class III2Distinct Products · 2 total registrations
About this profile

Access comprehensive registration holder profile for SUPER DIAGNOSTICA PRODS HOSP LTDA EPP through Pure Global AI's free Brazil medical device database. This registration holder manages 4 medical device registrations with ANVISA across 4 unique technical categories. Their regulatory portfolio spans from Feb 17, 2025 to Aug 11, 2025.

This page provides comprehensive insights including 4 recent product registrations with the latest being 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING (Neonatal 17-OH-Progesterone FEIA), 4 most popular products led by 17-HYDROXYPROGESTERONE (17-OHP) - NEONATAL SCREENING with 1 registrations, partnerships with 1 key manufacturers including LABSYSTEMS DIAGNOSTICS OY, and products across 2 risk classifications with 2 Class II devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.